Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.7%

7 terminated/withdrawn out of 51 trials

Success Rate

86.3%

-0.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

45%

20 of 44 completed trials have results

Key Signals

20 with results7 terminated

Enrollment Performance

Analytics

N/A
49(100.0%)
49Total
N/A(49)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (51)

Showing 20 of 51 trials
NCT04681352Not ApplicableCompleted

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Role: collaborator

NCT04795622Not ApplicableCompleted

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Role: collaborator

NCT02736825Not ApplicableTerminated

Simulines Non-Inferiority Pivotal Study

Role: lead

NCT01671839Not ApplicableCompleted

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Role: collaborator

NCT03351335Not ApplicableCompleted

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients

Role: collaborator

NCT03320096Not ApplicableCompleted

Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis

Role: lead

NCT03599349Not ApplicableCompleted

Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences

Role: lead

NCT02416076Not ApplicableCompleted

Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

Role: lead

NCT02441036Not ApplicableTerminated

Gene Expression Following Ultherapy® Treatment

Role: lead

NCT03545412Not ApplicableCompleted

Clinical Study on the Application of a Non-Invasive Micro-Focused Ultrasound With Visualization System for Skin Laxity (ULT-215)

Role: lead

NCT01810484Not ApplicableCompleted

Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

Role: lead

NCT02144181Not ApplicableCompleted

Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

Role: lead

NCT02270892Not ApplicableCompleted

Ultherapy for Buttock Lift

Role: lead

NCT02286804Not ApplicableCompleted

Ultherapy for the Treatment of Spider Veins on the Legs

Role: lead

NCT01519934Completed

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Role: lead

NCT01708551Not ApplicableCompleted

Histological Analysis Following Ulthera System Treatment for Hyperhidrosis

Role: lead

NCT02286765Not ApplicableCompleted

Ulthera® System for Treating Axillary Hyperhidrosis

Role: lead

NCT02145364Not ApplicableCompleted

Ultherapy® for the Treatment of Acne Scars

Role: lead

NCT01368874Not ApplicableCompleted

Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System

Role: lead

NCT01368835Not ApplicableCompleted

Evaluation of the Ulthera™ System for Obtaining Lift and Tightening of the Cheek Tissue

Role: lead